Showing results (201-210 of 317) with videos related to

Sort By:
Pageof 32
Blood|March 24, 2009
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Blood|August 23, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG reportFabiana Ostronoff, Megan Othus, Robert B Gerbing, et al.
Pediatric Blood & Cancer|August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology GroupRanjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Blood Cancer Journal|May 23, 2019
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 TrialRoya Rafiee, Lata Chauhan, Todd A Alonzo, et al.
Blood|April 24, 2010
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Rong Zeng, Todd A Alonzo, et al.
Preventive Medicine|November 26, 2019
The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El SalvadorNicole G Campos, Karla Alfaro, Mauricio Maza, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2019
Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: a randomized non-inferiority studyMiriam Cremer, Karla Alfaro, Jillian Garai, et al.
Blood|April 27, 2011
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaMarc Buyse, Pierre Squifflet, Beverly J Lange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology groupRoland B Walter, Todd A Alonzo, Robert B Gerbing, et al.
JCO Clinical Cancer Informatics|April 8, 2026
Childhood Cancer Data Initiative Participant Index: Mapping Pediatric Cancer Data to Facilitate Cross-Study Integrated AnalysisSubhashini Jagu, Jaime M Guidry Auvil, Mark D Cunningham, et al.
Pageof 32